The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course – a randomized, placebo‐controlled and double blind pilot study
Abstract
Background Our understanding of the pathogenic role of IgE in atopic dermatitis is incomplete. We asked whether blocking free IgE would alter the course of the disease. Patients and methods We administered either omalizumab, a humanized monoclonal mouse antibody against IgE, or placebo subcutaneously for 16 weeks to 20 atopic dermatitis patients and measured immunological and clinical disease parameters. Results Omalizumab (I) reduced free serum IgE, (II) lowered surface IgE and FcɛRI expression on different peripheral blood mononuclear cells, (III) reduced the saturation of FcɛRI with IgE, (IV) increased the number of free FcɛRI and (V) lowered the number of IgE+, but not of FcɛRI+ cells in skin. The in vivo relevance of these results is evidenced by the increase in the threshold allergen concentration required to give a type I hypersensitivity reaction in the titrated skin test. While not significantly altering the clinical disease parameters, omalizumab treatment led to an improvement of the atopy patch test results in single patients, i.e. an eczematous reaction upon epicutaneous allergen challenge. Conclusions The interference with immediate and delayed type skin tests may imply that a therapeutic benefit of omalizumab treatment, if present at all, would be seen in patients with acute rather than chronic forms of the disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“strategies aimed at depleting IgE with the anti-IgE biologic omalizumab failed to show convincing results in proof-of-concept studies and single cases107,108.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [107]
Citations
Cites
Diagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,597
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Leung, D. Y. M., & Bieber, T. R. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12193-9 · Cited by 1,164
Cytokine modulation of atopic dermatitis filaggrin skin expression
Howell, M. D., Kim, B. E., Gao, P., Grant, A. V., Boguniewicz, M., DeBenedetto, A., Schneider, L., Beck, L. A., Barnes, K. C., & Leung, D. Y. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.031 · Cited by 1,084
Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis
Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M., & TOKURA, Y. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.111 · Cited by 680
Djukanović, R., Wilson, S. J., Kraft, M., Jarjour, N. N., Steel, M. D., Chung, K. F., Bao, W., FowlerTaylor, A., Matthews, J. G., Busse, W. W., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200312-1651oc · Cited by 644
New developments in FcεRI regulation, function and inhibition
Kraft, S., & Kinet, J. (2007) · Nature reviews. Immunology · doi:10.1038/nri2072 · Cited by 580
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation
Holgate, S. T., Casale, T. B., Wenzel, S. E., Bousquet, J. J., Deniz, Y. M., & Reisner, C. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.11.053 · Cited by 468
Omalizumab-induced reductions in mast cell FcεRI expression and function
Beck, L. A., Marcotte, G. V., MacGlashan, D., Togias, A. G., & Saini, S. S. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.032 · Cited by 456
Cited by
Sorted by citations
Items 101–197 of 197
Autoimmunity, IgE and FcεRI-bearing cells
Charles, N. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.03.003 · Cited by 25
Systemic therapies in atopic dermatitis: The pipeline
Renert‐Yuval, Y., & Guttman‐Yassky, E. (2017) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2017.03.012 · Cited by 25
New and Emerging Biologics for Atopic Dermatitis
Baghoomian, W., Na, C. H., & Simpson, E. L. (2020) · American Journal of Clinical Dermatology · doi:10.1007/s40257-020-00515-1 · Cited by 24
Adjunctive Management of Itch in Atopic Dermatitis
Elmariah, S. B. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2017.02.011 · Cited by 24
Anti-IgE Treatment for Disorders Other Than Asthma
Stokes, J. R. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00152 · Cited by 23
Guía de dermatitis atópica. Consenso de la Sociedad Latinoamericana de Alergia, Asma e Inmunología
Sánchez, J., Páez, B., Macías-Weinmann, A., & Olmos-Olmos, C. (2014) · Revista Alergia México · doi:10.29262/ram.v61i3.43 · Cited by 22
Common and different roles of IL-4 and IL-13 in skin allergy and clinical implications
Roesner, L. M., Zeitvogel, J., & Heratizadeh, A. (2019) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000553 · Cited by 22
Autoreactive IgE: Pathogenic role and therapeutic target in autoimmune diseases
Charles, N., Krohn, I. K., Kocatürk, E., Scheffel, J., Altrichter, S., Steinert, C., Xiang, Y., Gutermuth, J., Reber, L. L., & Maurer, M. (2023) · Allergy · doi:10.1111/all.15843 · Cited by 21
Atopic dermatitis: a review of evolving targeted therapies
Kalamaha, K., Reis, E., Newton, S. L., Roche, C., Julson, J. R., Fernandes, H., & Rodrigues, J. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1560267 · Cited by 20
Bangert, C., Loesche, C., Skvara, H., Fölster‐Holst, R., Lacour, J. ‐., Jones, J. P., Burnett, P., Novak, N., & Stingl, G. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.01.040 · Cited by 20
Self-citationNovel Therapeutic Approaches to Atopic Dermatitis
Osinka, K., Dumycz, K., Kwiek, B., & Feleszko, W. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0487-1 · Cited by 18
Sánchez, J., Ramírez, R., Díez, S., Carrizosa, S. E. S., Echenique, A., Olivares, M., & Cardona, R. (2012) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2011.09.011 · Cited by 19
Chang, T. W., Chen, J.-B., & Chu, C. (2012) · Dermatologica Sinica · doi:10.1016/j.dsi.2012.10.001 · Cited by 19
Novel investigational therapies for atopic dermatitis
Ibler, K. S., & Jemec, G. B. E. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.957756 · Cited by 19
Biomarkers in atopic dermatitis: it is time to stratify
Ardern‐Jones, M. R., & Bieber, T. R. M. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13210 · Cited by 17
Novel therapies based on the pathophysiology of atopic dermatitis
Bieber, T. R. M. (2019) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13965 · Cited by 16
Management of Atopy with Dupilumab and Omalizumab in CADINS Disease
Diaz-Cabrera, N. M., Bauman, B. M., Iro, M. A., Dabbah‐Krancher, G., Molho‐Pessach, V., Zlotogorski, A., Shamriz, O., Dinur-Schejter, Y., Sharon, T. D., Stepensky, P., et al. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-023-01636-y · Cited by 16
Systemic treatment of adult atopic dermatitis
Cookson, H., & Smith, C. H. (2012) · Clinical Medicine · doi:10.7861/clinmedicine.12-2-172 · Cited by 16
Šolman, L., Lloyd-Lavery, A., Grindlay, D. J. C., Rogers, N. K., Thomas, K. S., & Harman, K. E. (2019) · Clinical and Experimental Dermatology · doi:10.1111/ced.13885 · Cited by 16
Dellon, E. S., Simon, D., & Wechsler, M. E. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.01.043 · Cited by 18
Therapie der schweren atopischen Dermatitis bei Erwachsenen
Deleuran, M. S., & Vestergaard, C. (2012) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2012.07899_suppl.x · Cited by 15
Monoclonal antibodies for the treatment of atopic dermatitis
Renert‐Yuval, Y., & Guttman‐Yassky, E. (2018) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000455 · Cited by 15
Effectiveness of ustekinumab in patients with atopic dermatitis: analysis of real-world evidence
Husein‐ElAhmed, H., & Steinhoff, M. S. (2021) · Journal of Dermatological Treatment · doi:10.1080/09546634.2021.1914315 · Cited by 16
Advances in Management of Atopic Dermatitis: New Therapies and Novel Uses of Existing Treatments
Chase, E. P., & Armstrong, A. W. (2012) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2011.11.005 · Cited by 15
The use of biologicals in cutaneous allergies – present and future
Makris, M. P., Papadavid, E., & Zuberbier, T. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000096 · Cited by 14
Advances in the Diagnosis and Therapeutic Management of Atopic Dermatitis
Vestergaard, C., & Deleuran, M. S. (2014) · Drugs · doi:10.1007/s40265-014-0219-3 · Cited by 14
Hutyrová, B., Bystroň, J., & Czech Anti-IgE Registry collaborators (2018) · Advances in Dermatology and Allergology · doi:10.5114/ada.2018.77243 · Cited by 14
Rossi, M., Rovati, C., Arisi, M., Tomasi, C., Calzavara‐Pinton, I., Venturini, M., & Calzavara‐Pinton, P. (2021) · Dermatology · doi:10.1159/000512456 · Cited by 13
A concept for integrated care pathways for atopic dermatitis—A GA 2 LEN ADCARE initiative
Zuberbier, T., Latiff, A. H. A., Aggelidis, X., Augustin, M., Bălan, R.-G., Bangert, C., Beck, L. A., Bieber, T. R. M., Bernstein, J. A., Bertolín‐Colilla, M., et al. (2023) · Clinical and Translational Allergy · doi:10.1002/clt2.12299 · Cited by 12
Quist, S., Ambach, A., Göppner, D., Quist, J., Franke, I., Bonnekoh, B., & Gollnick, H. P. M. (2013) · Acta Dermato Venereologica · doi:10.2340/00015555-1442 · Cited by 12
Mudnakudu-Nagaraju, K. K., Babina, M., & Worm, M. (2013) · Experimental Dermatology · doi:10.1111/exd.12261 · Cited by 12
Atopic Dermatitis: Drug Delivery Approaches in Disease Management
Lalan, M. S., Baweja, J., & Misra, A. R. (2015) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2015012114 · Cited by 12
Kulthanan, K., Chularojanamontri, L., Manapajon, A., & Nuchkull, P. (2011) · PubMed · Cited by 12
Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases
Kaufman, B. P., & Alexis, A. F. (2018) · Current Allergy and Asthma Reports · doi:10.1007/s11882-018-0804-8 · Cited by 11
Kanchongkittiphon, W., Gaffin, J. M., & Phipatanakul, W. (2014) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2014.08.016 · Cited by 11
New Drug Targets in Atopic Dermatitis
Simon, D., & Simon, H. (2012) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000331913 · Cited by 10
Aktualisierung„ Systemtherapie bei Neurodermitis“ zur S2k‐Leitlinie Neurodermitis
Werfel, T., Heratizadeh, A., Aberer, W., Ahrens, F., Augustin, M., Biedermann, T., Diepgen, T. L., Fölster‐Holst, R., Kahle, J., Kapp, A., et al. (2021) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14371_g · Cited by 10
Hołdrowicz, A., & Woźniacka, A. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061754 · Cited by 11
Immunotherapies in Dermatologic Disorders
Fallen, R. S., Terpstra, C. R., & Lima, H. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.04.004 · Cited by 9
Dupilumab for the treatment of atopic dermatitis: A clinical trial review
McGregor, S. P., Farhangian, M. E., & Feldman, S. R. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1076388 · Cited by 9
Pruritus and Atopic Dermatitis: from Etiological Features to Management
Murashkin, N. N., Opryatin, L. A., Epishev, R. V., Materikin, A. I., Ambarchian, E. Т., Ivanov, R. A., Fedorov, D. V., & Kukoleva, D. S. (2020) · Вопросы современной педиатрии · doi:10.15690/vsp.v19i6.2151 · Cited by 9
Zang, C., Cai, M., Chen, Q., Yu, M., Yan, J., Guo, Y., Wang, M., Wu, C., Gao, Y., & Qi, Y. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120267 · Cited by 8
Single‐use IgE‐selective immunoadsorber column for the treatment of severe atopic dermatitis
Meyersburg, D., Laimer, M., Kugler, A., Mühlthaler, E., Lindlbauer, N., Hitzl, W., Rohde, E., Bauer, J. W., & Grabmer, C. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21759 · Cited by 8
Therapy of severe atopic dermatitis in adults
Deleuran, M. S., & Vestergaard, C. (2012) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2012.07899.x · Cited by 8
The Evolution of IgE-Based Allergy Testing in Atopic Dermatitis: Where Do We Stand?
Braun, C., Graham, F. J., Fleischer, D. M., Molloy, J., Bégin, P., & Eigenmann, P. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.05.013 · Cited by 7
Recent Advances of Basophils in Pruritic Skin Diseases
Liu, W., Xu, R., & Wang, F. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.12.005 · Cited by 7
Systemic Treatment of Severe Atopic Dermatitis in Children and Adults
Nygaard, U., Vestergaard, C., & Deleuran, M. S. (2014) · Current Treatment Options in Allergy · doi:10.1007/s40521-014-0032-y · Cited by 7
A translational approach to improve therapeutics in atopic dermatitis and beyond
Liu, D., Patel, D., Lau, M., Largen, J., Hu, B., He, H., & Guttman‐Yassky, E. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf049 · Cited by 7
The place of Omalizumab in the treatment of allergic diseases
Kurbacheva, O. M., & Galitskaya, M. A. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-15-38-49 · Cited by 7
Omalizumab for severe atopic dermatitis in 4- to 19-year-olds: the ADAPT RCT
Chan, S., Cro, S., Cornelius, V. R., Jahan, R., Radulović, S., & Lack, G. (2022) · Efficacy and Mechanism Evaluation · doi:10.3310/wcxn5739 · Cited by 5
Guía de dermatitis atópica para México (GUIDAMEX): lineamientos usando metodología ADAPTE
Larenas‐Linnemann, D. E., Pérez, C. R., Luna-Pech, J. A., Macías-Weinmann, A., la Cruz, H. V., Navarrete-Rodriguez, E. M., Del-Rio-Navarro, B. E., Godínez-Aldrete, L., Guevara‐Sanginés, E., Ortega‐Martell, J. A., et al. (2023) · Gaceta Médica de México · doi:10.24875/gmm.m22000690 · Cited by 5
Omalizumab for the treatment of atopic dermatitis
Eguíluz‐Gracia, I., Echarren, T. R., Suárez‐Fernández, R., Fernández‐Rivas, M., & Sánchez‐Ramón, S. (2015) · Clinical Investigation · doi:10.4155/cli.14.108 · Cited by 5
Hong, J. Y., Bae, J.-H., Lee, K. E., Kim, M. N., Kim, M. H., Kang, H. J., Park, E. H., Yoo, K. S., Jeong, S. K., Kim, K. W., et al. (2016) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.6.1412 · Cited by 5
Drozhdina, M. B., & Викторовна, С. Е. (2021) · Medical Immunology (Russia) · doi:10.15789/1563-0625-iri-2138 · Cited by 6
Nečas, M., Vašků, V., & Březinová, E. (2019) · Acta Dermatovenerologica Alpina Pannonica et Adriatica · doi:10.15570/actaapa.2019.22 · Cited by 5
Allergie und atopische Dermatitis — ausgewählte Aspekte aus Klinik und Forschung
Werfel, T. (2012) · Allergo Journal · doi:10.1007/s15007-012-0444-6 · Cited by 4
Atopic Dermatitis and Allergic Contact Dermatitis
Leung, D. Y. M., & Boguniewicz, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37579-5.00011-8 · Cited by 4
Systemic treatments for eczema: a network meta-analysis
Sawangjit, R., Dilokthornsakul, P., Lloyd-Lavery, A., Chua, S. K. J., Lai, N. M., Dellavalle, R. P., & Chaiyakunapruk, N. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013206 · Cited by 4
Esposito, M., Giunta, A., Berardinis, A. D., Magnanimi, L. M., Fargnoli, M. C., Patruno, C., Potestio, L., & Napolitano, M. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01536-6 · Cited by 3
Neues und Bewährtes zur Therapie des atopischen Ekzems
Fölster‐Holst, R. (2012) · Allergo Journal · doi:10.1007/s15007-012-0391-2 · Cited by 3
Chiricozzi, A., Peroni, D. G., & Girolomoni, G. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1516748 · Cited by 3
Lee, G. R., Lee, D. E., & Shi, V. Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-84744-5.00023-1 · Cited by 3
Biological Therapeutic Treatment of Atopic Dermatitis
Kubanova, A. A., Kubanov, A. A., Karamova, A. Е., & Proshutinskaya, D. V. (2017) · Vestnik dermatologii i venerologii · doi:10.25208/0042-4609-2017-93-5-34-46 · Cited by 3
Hamilton, J. D., Ferreira, M. A. R., Lim, W. K., Sidore, C., Wipperman, M. F., Ge, W., Song, X., Xia, C., Horowitz, J. E., Hooper, A. T., et al. (2026) · Allergy · doi:10.1111/all.70380 · Cited by 3
Boguniewicz, M., & Leung, D. Y. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-08593-9.00035-8 · Cited by 2
Inflammatory skin diseases: The importance of immunological signatures
Garzorz‐Stark, N., Weidinger, S., Sticherling, M., Ghoreschi, K., Enk, A. H., & Eyerich, K. (2025) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2025.0045 · Cited by 3
Evaluation of efficacy of anti-IgE monoclonal antibody treatment not only in severe allergic asthma
Bystroň, J., & Hutyrová, B. (2016) · Klinická farmakologie a farmacie · doi:10.36290/far.2016.036 · Cited by 2
Neuartige Therapien auf der Grundlage der Pathophysiologie der atopischen Dermatitis
Bieber, T. R. M. (2019) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13965_g · Cited by 2
Therapy of severe atopic dermatitis in adults
Deleuran, M. S., & Vestergaard, C. (2012) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2012.12506.x · Cited by 2
Atopic Dermatitis Triggered by Omalizumab and Treated With Dupilumab
Yanovsky, R. L. (2023) · Cutis · doi:10.12788/cutis.0878 · Cited by 2
Biologika-Therapie der atopischen Dermatitis
Quint, T., & Bangert, C. (2020) · hautnah · doi:10.1007/s12326-020-00418-2 · Cited by 1
A multidimensional analysis of prognostic factors in atopic dermatitis
Liu, Z., Guo, M., Li, Y., & Xu, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1554669 · Cited by 1
Nagata, Y., & Suzuki, R. (2025) · European Journal of Immunology · doi:10.1002/eji.70117 · Cited by 1
Κατσαρού, Α., Armenaka, M. C., Zafiriou, E., & Vakirlis, E. (2016) · Springer eBooks · doi:10.1007/978-3-662-47398-6_62 · Cited by 1
Prescription Treatment Options
Ackerson, B. G., Thorpe, R. K., & Nicholas, M. W. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-64804-0_10 · Cited by 1
Review of the 94th Annual Meeting of the British Association of Dermatologists, Glasgow 2014
Porter, R. M., & George, S. M. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13762 · Cited by 1
Biologics for the Treatment of Atopic Dermatitis
Hajar, T., Hill, E., & Simpson, E. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-66884-0_31 · Cited by 1
Additional Biologic Therapeutics
Grinich, E. E., & Simpson, E. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-61211-1.00031-0 · Cited by 1
Actualidades en el tratamiento sistémico de la dermatitis atópica en el paciente pediátrico
Cruz, P. G., Lagunes, C. G. Z., & López, J. G. H. (2015) · Alergia, Asma e Inmunología Pediátricas
Omalizumab Therapy for Allergic Diseases
(2013) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608057184113010006
Pathogeneseorientierte moderne Therapie der atopischen Dermatitis
Biedermann, T., & Werfel, T. (2015) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-014-3167-9
Omalizumab en indicaciones diferentes al asma alérgica
de Llano, L. P., & Arrondo, A. P. (2015) · Monografías de Archivos de Bronconeumología
Neue Wirkstoffe in der Pipeline zur Behandlung der atopischen Dermatitis
Bangert, C. (2016) · ästhetische dermatologie & kosmetologie · doi:10.1007/s12634-016-5232-1
Aktuelle Aspekte zum atopischen Ekzem
Werfel, T. (2013) · Fortschritte der praktischen Dermatologie und Venerologie · doi:10.1007/978-3-642-24767-5_50
Systemic Therapy of Atopic Dermatitis: When, How, for How Long?
Malik, K., & Guttman‐Yassky, E. (2017) · Current Dermatology Reports · doi:10.1007/s13671-017-0176-7
Maderal, A. D., & Berman, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-66884-0_38
Dermatitis atópica del adulto: de la fisiopatología a la terapéutica (II)
Rodríguez, J., Alcantara‐Luna, S., Hita, J. C. A., & Martínez-Pilar, L. (2018) · Piel · doi:10.1016/j.piel.2018.01.015
Current trends in the treatment of skin allergies
Janoušková, G., & Machovcová, A. (2019) · Dermatologie pro praxi · doi:10.36290/der.2019.012
Atopic dermatitis in children: up to date insight on development and trends in therapy
Балаболкин, И. И. (2020) · Russian Pediatric Journal · doi:10.18821/1560-9561-2020-23-4-265-270
Nakajima‐Adachi, H., Tran, K. A., & Shimoda, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-84744-5.00013-9
Gocki, J., Romańska-Gocka, K., & Bartuzi, Z. (2016) · Alergologia Polska - Polish Journal of Allergology · doi:10.1016/j.alergo.2016.10.003
Principles of Systemic Therapy
Pink, A., Woolf, R., & Smith, C. H. (2024) · Wiley eBooks · doi:10.1002/9781119709268.rook019
Shnaider, K. O., Kondrakhin, A. P., Maksimov, М. L., Belokopytov, A., Smirnova, Y. E., Babichev, A., & Gibadatov, B. U. (2025) · Glavvrač (Chief Medical Officer) · doi:10.33920/med-03-2508-01
Anti -IL-4, -IL-13 and -IgE vaccination for the treatment of allergic diseases
Conde, E. (2020) · theses.fr (ABES) · doi:10.70675/595ec855zeea2z4557z95b5z4de5bf043ffd
Savinko, T. (2013) · Työväentutkimus Vuosikirja
Metadata
- Authors
- Heil, P. M., Maurer, D., Klein, B., Hultsch, T., & Stingl, G.
- Affiliations
- Medical University of Vienna (AT)
- Johannes Gutenberg University Mainz (DE)
- Venue
- JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Publisher
- Wiley
- Published
- 2010-11-25
- Volume
- 8
- Issue
- 12
- Pages
- 990-998
- ISSN
- 1610-0379 (ISSN-L)
- 1610-0387
- OpenAlex
- W1512818159
- Cited by
- 197
- References
- 38
- Citations by year
- 2026: 1 · 2025: 11 · 2024: 3 · 2023: 10 · 2022: 6 · 2021: 14 · 2020: 10 · 2019: 14 · 2018: 12 · 2017: 19 · 2016: 24 · 2015: 24 · 2014: 13 · 2013: 15 · 2012: 16
- FWCI
- 13.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JDDG Journal der Deutschen Dermatologischen Gesellschaft (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Keywords
- omalizumab, atopic dermatitis, IgE, FcεRI, immediate hypersensitivity, atopy patch test, chronic atopic dermatitis
- MeSH terms
- Omalizumab, Adolescent, Adult, Antibodies, Anti-Idiotypic, Antibodies, Monoclonal, Dermatitis, Atopic, Double-Blind Method, Female, Humans, Immunoglobulin E, Injections, Subcutaneous, Male, Middle Aged, Pilot Projects, Skin Tests, Placebo Effect, Treatment Outcome, Anti-Allergic Agents, Young Adult, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
